<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Metab Res Rev</journal-id><journal-id journal-id-type="iso-abbrev">Diabetes Metab. Res. Rev</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1520-7560</journal-id><journal-id journal-id-type="publisher-id">DMRR</journal-id><journal-title-group><journal-title>Diabetes/Metabolism Research and Reviews</journal-title></journal-title-group><issn pub-type="ppub">1520-7552</issn><issn pub-type="epub">1520-7560</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29929213</article-id><article-id pub-id-type="pmc">6220847</article-id><article-id pub-id-type="doi">10.1002/dmrr.3043</article-id><article-id pub-id-type="publisher-id">DMRR3043</article-id><article-id pub-id-type="other">DMRR-18-REV-034.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Gut microbiome in type 1 diabetes: A comprehensive review</article-title><alt-title alt-title-type="left-running-head">Zheng et al.</alt-title></title-group><contrib-group><contrib id="dmrr3043-cr-0001" contrib-type="author"><name><surname>Zheng</surname><given-names>Peilin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4712-4903</contrib-id><xref ref-type="aff" rid="dmrr3043-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="dmrr3043-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="dmrr3043-cr-0002" contrib-type="author"><name><surname>Li</surname><given-names>Zhixia</given-names></name><xref ref-type="aff" rid="dmrr3043-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="dmrr3043-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="dmrr3043-cr-0003" contrib-type="author" corresp="yes"><name><surname>Zhou</surname><given-names>Zhiguang</given-names></name><address><email>zhouzhiguang@csu.edu.cn</email></address><xref ref-type="aff" rid="dmrr3043-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="dmrr3043-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="dmrr3043-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Metabolism and Endocrinology, The Second Xiangya Hospital</named-content>
<institution>Central South University</institution>
<named-content content-type="city">Changsha</named-content>
<country country="CN">China</country>
</aff><aff id="dmrr3043-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education</named-content>
<institution>National Clinical Research Center for Metabolic Diseases</institution>
<named-content content-type="city">Changsha</named-content>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Zhiguang Zhou, Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, 139 Ren Min Middle Road, Changsha, Hunan 410011, China.<break/>
Email: <email>zhouzhiguang@csu.edu.cn</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2018</year></pub-date><volume>34</volume><issue>7</issue><issue-id pub-id-type="doi">10.1002/dmrr.v34.7</issue-id><elocation-id>e3043</elocation-id><history><date date-type="received"><day>06</day><month>2</month><year>2018</year></date><date date-type="rev-recd"><day>06</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>14</day><month>6</month><year>2018</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 John Wiley & Sons, Ltd. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2018 The Authors. Diabetes/Metabolism Research and Reviews Published by John Wiley &#x00026; Sons Ltd</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:DMRR-34-na.pdf"/><abstract><title>Summary</title><p>Type 1 diabetes (T1D) is an autoimmune disease, which is characterized by the destruction of islet &#x003b2; cells in the pancreas triggered by genetic and environmental factors. In past decades, extensive familial and genome&#x02010;wide association studies have revealed more than 50 risk loci in the genome. However, genetic susceptibility cannot explain the increased incidence of T1D worldwide, which is very likely attributed by the growing impact of environmental factors, especially gut microbiome. Recently, the role of gut microbiome in the pathogenesis of T1D has been uncovered by the increasing evidence from both human subjects and animal models, strongly indicating that gut microbiome might be a pivotal hub of T1D&#x02010;triggering factors, especially environmental factors. In this review, we summarize the current aetiological and mechanism studies of gut microbiome in T1D. A better understanding of the role of gut microbiome in T1D may provide us with powerful prognostic and therapeutic tools in the near future.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="dmrr3043-kwd-0001">environmental factors</kwd><kwd id="dmrr3043-kwd-0002">genetics</kwd><kwd id="dmrr3043-kwd-0003">gut microbiome</kwd><kwd id="dmrr3043-kwd-0004">immune system</kwd><kwd id="dmrr3043-kwd-0005">type 1 diabetes</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>81500600</award-id><award-id>81670716</award-id><award-id>81461168031</award-id></award-group><award-group><funding-source>Central South University</funding-source><award-id>502211703</award-id></award-group><award-group><funding-source>National Science and Technology Infrastructure Program</funding-source><award-id>2015BAI12B13</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="9"/><word-count count="4592"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>dmrr3043</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>October 2018</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.1 mode:remove_FC converted:07.11.2018</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="dmrr3043-cit-0001">
<string-name>
<surname>Zheng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Gut microbiome in type 1 diabetes: A comprehensive review</article-title>. <source xml:lang="en">Diabetes Metab Res Rev</source>. <year>2018</year>;<volume>34</volume>:<elocation-id>e3043</elocation-id>
<pub-id pub-id-type="doi">10.1002/dmrr.3043</pub-id>
<pub-id pub-id-type="pmid">29929213</pub-id></mixed-citation>
</p></notes></front><body><sec id="dmrr3043-sec-0001"><label>1</label><title>INTRODUCTION OF TYPE 1 DIABETES</title><p>Type 1 diabetes (T1D) is an organ&#x02010;specific autoimmune disease due to T lymphocytes and other immune cell infiltrating and attacking pancreatic &#x003b2; cells, resulting in the destruction of &#x003b2; cells and progression to insulin deficiency.<xref rid="dmrr3043-bib-0001" ref-type="ref">1</xref> Type 1 diabetes is consisted of 2 subtypes. The majority of T1D is the autoimmune type (T1A), with a smaller proportion being the non&#x02010;autoimmune type, also known as the idiopathic type 1 diabetes (T1B). In clinical practice, islet cell autoantibodies, including anti&#x02010;insulin autoantibody (IAA), glutamic acid decarboxylase antibody (GADA), anti&#x02010;protein tyrosine phosphatase like protein (IA&#x02010;2A) and zinc transporter 8 antibody (ZnT8A) are used to diagnose T1A and identify high&#x02010;risk subjects.<xref rid="dmrr3043-bib-0002" ref-type="ref">2</xref>, <xref rid="dmrr3043-bib-0003" ref-type="ref">3</xref>, <xref rid="dmrr3043-bib-0004" ref-type="ref">4</xref> Epidemiologically, incidence of T1D increases at a rate of 3% to 5% per year.<xref rid="dmrr3043-bib-0005" ref-type="ref">5</xref> Moreover, multiple factors influence the susceptibility to T1D, including genetic and environmental factors. Although gender is a very important factor in a variety of autoimmune diseases (women are generally more susceptible than men), there is no gender difference in the prevalence of T1D in humans.<xref rid="dmrr3043-bib-0006" ref-type="ref">6</xref>, <xref rid="dmrr3043-bib-0007" ref-type="ref">7</xref>, <xref rid="dmrr3043-bib-0008" ref-type="ref">8</xref>
</p><p>With regard to genetic factors, more than 50 T1D susceptibility genes have been uncovered by familial linkage analysis and genome&#x02010;wide association studies. Notably, not every gene contributes to T1D susceptibility equally. Particularly, the HLA&#x02010;DR and &#x02010;DQ genes account for approximately 40% to 50% of the disease risk.<xref rid="dmrr3043-bib-0009" ref-type="ref">9</xref>, <xref rid="dmrr3043-bib-0010" ref-type="ref">10</xref>, <xref rid="dmrr3043-bib-0011" ref-type="ref">11</xref> Other susceptibility genes, including PTPN22, IL2Ra, and CTLA4 are also interrelated closely with T1D.<xref rid="dmrr3043-bib-0012" ref-type="ref">12</xref>, <xref rid="dmrr3043-bib-0013" ref-type="ref">13</xref>, <xref rid="dmrr3043-bib-0014" ref-type="ref">14</xref>
</p><p>Environmental factors are considered to be another essential modulator of T1D.<xref rid="dmrr3043-bib-0015" ref-type="ref">15</xref>, <xref rid="dmrr3043-bib-0016" ref-type="ref">16</xref> In the islets of newly diagnosed diabetic children, an abundance of IFN&#x02010;&#x003b3; and HLA could be found, indicating that viral infection may be involved in T1D. Subsequent studies demonstrated that viruses, especially, enterovirus and Coxsackie B virus, may speed up the progression of T1D, potentially by directly inducing insulitis or activating immune system through molecular mimicry of islet autoantigens.<xref rid="dmrr3043-bib-0017" ref-type="ref">17</xref>, <xref rid="dmrr3043-bib-0018" ref-type="ref">18</xref> Diet is another environmental factor influencing disease susceptibility. In non&#x02010;obese diabetic (NOD) mice, gluten&#x02010;free diet delayed diabetes, and early dietary exposure to cow's milk proteins accelerated T1D, which is possibly because of the fact that albumin in cow's milk is a molecular mimic of ICA&#x02010;1, a surface protein on &#x003b2; cells.<xref rid="dmrr3043-bib-0019" ref-type="ref">19</xref> Vitamin D is thought to be the protective factor against T1D, and the deficiency of vitamin D may increase the risk of T1D.<xref rid="dmrr3043-bib-0020" ref-type="ref">20</xref>, <xref rid="dmrr3043-bib-0021" ref-type="ref">21</xref> In addition, antibiotics have been used to treat infections for more than 50&#x000a0;years. In the last few years, researchers believed that the abuse of antibiotics is correlated with the increased incidence of T1D, but its exact role is still controversial. While some literature suggested antibiotics usage in early life increased T1D susceptibility, another study reported antibiotics protected from T1D in Bio&#x02010;Breeding diabetes&#x02010;prone (BB&#x02010;DP) rat or in NOD mice by modulating gut microbiome.<xref rid="dmrr3043-bib-0022" ref-type="ref">22</xref>, <xref rid="dmrr3043-bib-0023" ref-type="ref">23</xref>, <xref rid="dmrr3043-bib-0024" ref-type="ref">24</xref> Mikkelsen and colleagues showed that antibiotics usage within 1&#x000a0;year had nothing to do with the risk of developing T1D.<xref rid="dmrr3043-bib-0025" ref-type="ref">25</xref>
</p></sec><sec id="dmrr3043-sec-0002"><label>2</label><title>GUT MICROBIOME AND TYPE 1 DIABETES</title><sec id="dmrr3043-sec-0003"><label>2.1</label><title>Introduction of gut microbiome</title><p>Gut microbiome contains approximately 500 to 1000 different bacterial species and 100 trillion (10<xref rid="dmrr3043-bib-0014" ref-type="ref">14</xref>) bacteria residing in gastrointestinal tract. Because of the symbiotic relationship between gut microbiome and our body, gut microbiome also is called commensal bacteria.<xref rid="dmrr3043-bib-0026" ref-type="ref">26</xref> Microbes in the gut and intestine are generally divided into Gram&#x02010;positive (G+) and Gram&#x02010;negative (G&#x02212;) populations.<xref rid="dmrr3043-bib-0027" ref-type="ref">27</xref>, <xref rid="dmrr3043-bib-0028" ref-type="ref">28</xref> Usually, gastrointestinal tracts are dominated by 4 bacterial phyla based on 16S rRNA sequencing, including <italic>Firmicutes</italic>, <italic>Bacteroides</italic>, <italic>Proteobacteria</italic>, and <italic>Actinobacteria</italic>.<xref rid="dmrr3043-bib-0029" ref-type="ref">29</xref>
<italic>Firmicutes and Bacteroidetes</italic> constitute the most abundant phyla in the adult's gut and intestine, and <italic>Actinobacteria</italic> is predominant in the gut of breast&#x02010;fed infants.<xref rid="dmrr3043-bib-0030" ref-type="ref">30</xref>
<italic>Bifidobacterium</italic> is the most abundant bacteria in <italic>Actinobacteria</italic> and considered to be probiotic microorganisms. Here we quote the definition of microbiota and microbiome by Samantha and Whiteside.<xref rid="dmrr3043-bib-0031" ref-type="ref">31</xref> Microbiota refers to microorganisms in a particular environment and can be detected by 16S rRNA sequencing. However, microbiome refers to a larger range, including not only 16S rRNA region but also the whole bacterial genome and products.<xref rid="dmrr3043-bib-0031" ref-type="ref">31</xref>
</p></sec><sec id="dmrr3043-sec-0004"><label>2.2</label><title>The role of gut microbiome in T1D</title><p>Gut microbiome maintains a constantly dynamic and homeostatic condition. However, at the same time, it can be affected by multiple factors. During childbirth, gut microbiome in infants is largely determined by delivery mode. A study showed that gut microbes in vaginally delivered infants were closer to the mother's vaginal microbiome. In contrast, bacteria in the gut of infants who were delivered through C&#x02010;section were similar to those on mother's skin surface.<xref rid="dmrr3043-bib-0032" ref-type="ref">32</xref> Additionally, Biasucci and colleagues demonstrated that caesarean delivery affected the early biodiversity of intestinal bacteria of the newborn, indicating that the mode of delivery could influence the composition of intestinal bacteria substantially.<xref rid="dmrr3043-bib-0033" ref-type="ref">33</xref> After childbirth, gut microbiome is largely affected by diet, antibiotics usage, medicine, and even pH value of drinking water. For example, high&#x02010;fat and high&#x02010;sugar diet affected the incidence of diabetes by causing dysbiosis of gut microbiota, particularly the decreased <italic>Bifidobacteria</italic> spp.<xref rid="dmrr3043-bib-0034" ref-type="ref">34</xref> In NOD mice, treatment with a broad&#x02010;spectrum antibiotic altered the composition of gut microbes and decreased the proportion of regulatory T cells (Tregs) in the intestinal lamina propria, resulting in an increased incidence of T1D.<xref rid="dmrr3043-bib-0022" ref-type="ref">22</xref> On the contrary, Hu and colleagues reported that NOD mice received with antibiotics were protected from T1D development. In particular, when mothers were treated with antibiotics, the offspring could also be protected from T1D with an unknown mechanism.<xref rid="dmrr3043-bib-0035" ref-type="ref">35</xref> Another study showed that although antibiotic treatment in NOD mice changed insulin sensitivity as well as the composition of gut microbes, gut permeability was not altered in the following 8&#x000a0;weeks.<xref rid="dmrr3043-bib-0036" ref-type="ref">36</xref> Therefore, the impact of antibiotic treatment on gut microbiome and T1D is far from conclusive and may depend on the specific antibiotic used and time window of usage. Proton pump inhibitors are mainly used to depress gastric acid production and treat peptic ulcers. Treatment of proton pump inhibitors lowered gut microbial diversity<sub>.</sub>
<xref rid="dmrr3043-bib-0037" ref-type="ref">37</xref> The pH value of drinking water also influenced the composition and diversity of intestine bacteria.<xref rid="dmrr3043-bib-0038" ref-type="ref">38</xref>, <xref rid="dmrr3043-bib-0039" ref-type="ref">39</xref> In conclusion, multiple factors can affect gut microbiome. The dysregulation of gut microbiome is closely involved in the pathogenesis of T1D.<xref rid="dmrr3043-bib-0040" ref-type="ref">40</xref>
</p><p>Gut microbiome is regarded as another essential modulator of T1D susceptibility in recent years, illustrated by a very quickly growing number of studies reported. In 2008, Wen and colleagues found that specific pathogen free (SPF) condition protected myeloid differentiation primary response gene88 (MyD88)&#x02013;deficient NOD mice from T1D. However, germ&#x02010;free (GF) environment reversed the disease protection in those mice, indicating that gut microbiome might be a critical factor in T1D pathogenesis.<xref rid="dmrr3043-bib-0041" ref-type="ref">41</xref> The following studies showed that <styled-content style="fixed-case"><styled-content style="italic-in-any-context">Bacillus cereus</styled-content></styled-content> could delay T1D onset and decrease disease incidence in GF NOD mice and BB&#x02010;DP rats.<xref rid="dmrr3043-bib-0042" ref-type="ref">42</xref> Bacterium <italic>A. muciniphila</italic> protected NOD mice from T1D, especially during infancy, suggesting that early postpartum was a critical time for the microbial protective role to take place.<xref rid="dmrr3043-bib-0024" ref-type="ref">24</xref> However, some peptides secreted by certain bacteria in the gut mimicked pancreatic autoantigen and activated diabetogenic CD8 T cells to accelerate insulitis in NOD mice.<xref rid="dmrr3043-bib-0043" ref-type="ref">43</xref> Similarly, <italic>Citrobacter rodentium</italic> was shown to promote the development of T1D.<xref rid="dmrr3043-bib-0029" ref-type="ref">29</xref> All these studies demonstrated that gut microbiome may be a pivotal modulator in T1D pathogenesis.</p></sec><sec id="dmrr3043-sec-0005"><label>2.3</label><title>Taxonomic changes of gut microbiome in T1D pathogenesis</title><p>Taxonomic study of gut microflora is usually performed by 16S rRNA sequencing to identify the classification of phylum, family, genus, and species of gut microbes. Taxonomic changes of gut microbiome in T1D have been uncovered by a number of longitudinal as well as cross&#x02010;sectional case&#x02010;control studies in humans and experiments in animals (Table&#x000a0;<xref rid="dmrr3043-tbl-0001" ref-type="table">1</xref>). In 2011, a longitudinal case&#x02010;control study was carried out by Knip and colleagues to explore the relationship between gut microbiome and T1D. The 16S pyrosequencing data showed that children with positive islet&#x02010;autoantibodies had higher <italic>Bacteroidetes/Firmicutes</italic> ratio and lower Shannon diversity existed in the gut microbiome.<xref rid="dmrr3043-bib-0044" ref-type="ref">44</xref>, <xref rid="dmrr3043-bib-0045" ref-type="ref">45</xref> Further studies indicated that <italic>Bacteroides dorei</italic> and <italic>vulgatus</italic> were significantly accumulated in children with high risk of T1D<xref rid="dmrr3043-bib-0046" ref-type="ref">46</xref>, <xref rid="dmrr3043-bib-0047" ref-type="ref">47</xref> and associated with autoantibody positivity.<xref rid="dmrr3043-bib-0048" ref-type="ref">48</xref>, <xref rid="dmrr3043-bib-0049" ref-type="ref">49</xref> The abundance of short&#x02010;chain fatty acids (SCFAs)&#x02010;producing bacteria as well as lactate&#x02010;producing bacteria was reduced in T1D patients.<xref rid="dmrr3043-bib-0050" ref-type="ref">50</xref> The reduced number of <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> could also be observed at the onset of T1D.<xref rid="dmrr3043-bib-0051" ref-type="ref">51</xref> Similar results were replicated in animals, illustrated by the fact that more <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> could be found in bio&#x02010;breeding diabetes&#x02010;resistant rat but less in T1D&#x02010;prone BB&#x02010;DP rats.<xref rid="dmrr3043-bib-0052" ref-type="ref">52</xref>
</p><table-wrap id="dmrr3043-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>The summary of changes in gut microbiome and possible effects in T1D</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Changes in Gut Microbes</th><th align="left" valign="bottom" rowspan="1" colspan="1">Possible Effects or Function</th><th align="left" valign="bottom" rowspan="1" colspan="1">Refs</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<styled-content style="fixed-case"><styled-content style="italic-in-any-context">Clostridium perfringens</styled-content></styled-content> &#x02191;<break/>
<italic>Dialister invisus</italic> &#x02191;<break/>
<italic>Gemella sanguinis</italic> &#x02191;<break/>
<italic>Bifidobacterium longum</italic> &#x02191;<break/>
<italic>Prevotella</italic> &#x02193;<break/>
Akkermansia &#x02193;<break/>
Bifidobacterium adolescentis &#x02193;<break/>
Roseburia faecis &#x02193;<break/>
Faecalibacterium prausnitzii &#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">
Intestinal integrity &#x02193;<break/>
Gut permeability &#x02191;<break/>
Inflammation &#x02191;<break/>
T1D predisposition &#x02191;</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="dmrr3043-bib-0029" ref-type="ref">29</xref>, <xref rid="dmrr3043-bib-0048" ref-type="ref">48</xref>
<break/>
<xref rid="dmrr3043-bib-0050" ref-type="ref">50</xref>, <xref rid="dmrr3043-bib-0057" ref-type="ref">57</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leptotrichia goodfellowii</italic> &#x02191;<break/>
<styled-content style="fixed-case"><styled-content style="italic-in-any-context">Bacillus cereus</styled-content></styled-content> &#x02191;<break/>
<italic>Enterobacter mori LMG 25706</italic> &#x02191;</td><td align="left" valign="top" rowspan="1" colspan="1">
Molecular mimicry<break/>
Activate diabetogenic T cells<break/>
T1D risk &#x02191;</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="dmrr3043-bib-0043" ref-type="ref">43</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Bacteroidetes</italic>/<italic>Firmicutes</italic> &#x02191;</td><td align="left" valign="top" rowspan="1" colspan="1">
Occurs before and at the<break/>
Diagnosis of T1D</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="dmrr3043-bib-0045" ref-type="ref">45</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Bacteroides dorei</italic> &#x02191;<break/>
<italic>Bacteroides vulgatus</italic> &#x02191;<break/>
Faecalibacterium prausnitzii &#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">
Involved in multiple autoimmune diseases<break/>
Disruption of the epithelial layer?<break/>
Manipulation of immune system?</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="dmrr3043-bib-0046" ref-type="ref">46</xref>, <xref rid="dmrr3043-bib-0047" ref-type="ref">47</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Bifidobacteria</italic> &#x02193;<break/>
Bacteroides genus &#x02191;</td><td align="left" valign="top" rowspan="1" colspan="1">
Butyrate &#x02193;<break/>
Bacterial translocation &#x02191;<break/>
T1D predisposition &#x02191;</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="dmrr3043-bib-0048" ref-type="ref">48</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
Bacteroides adolescentis &#x02193;<break/>
Roseburia faecis &#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">
Regulatory T cells &#x02193;<break/>
T1D risk &#x02191;</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="dmrr3043-bib-0048" ref-type="ref">48</xref>, <xref rid="dmrr3043-bib-0049" ref-type="ref">49</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diversity &#x02193;</td><td align="left" valign="top" rowspan="1" colspan="1">
SCFAs &#x02193;<break/>
Inflammation &#x02191;<break/>
T1D predisposition &#x02191;</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="dmrr3043-bib-0054" ref-type="ref">54</xref>, <xref rid="dmrr3043-bib-0055" ref-type="ref">55</xref>
</td></tr></tbody></table></table-wrap><p>Several cross&#x02010;sectional case&#x02010;control studies have been performed to reveal the differences of gut microbiome between T1D patients and healthy control subjects. When compared with healthy subjects, more phylum <italic>Bacteroidetes</italic> and lower abundance of 2 dominant <italic>Bifidobacterium</italic> species were found in T1D children.<xref rid="dmrr3043-bib-0047" ref-type="ref">47</xref> Mej&#x000ed;a&#x02010;Le&#x000f3;n and Barca compared gut microbiome in patients with newly diagnosed T1D, patients with T1D duration, and healthy controls. The results showed that that newly diagnosed T1D patients had an increased abundance of <italic>Bacteroides</italic>, whereas healthy control possessed more <italic>Prevotella</italic>.<xref rid="dmrr3043-bib-0053" ref-type="ref">53</xref>
</p><p>The changes in the composition of gut microflora in T1D result in the altered diversity of gut microbes. Several studies recruited children with islet autoantibody positivity and later progressed to clinical diagnosis of T1D and found the reduced diversity of intestinal bacteria before the disease onset.<xref rid="dmrr3043-bib-0054" ref-type="ref">54</xref> Similarly, reduced diversity of gut microbes was found in diabetic Sprague&#x02010;Dawley rats with Streptozotocin injection.<xref rid="dmrr3043-bib-0055" ref-type="ref">55</xref> All these data demonstrated that alteration in gut bacteria is closely related to T1D in both humans and animal models.</p></sec><sec id="dmrr3043-sec-0006"><label>2.4</label><title>Mechanism of gut microbiome in T1D pathogenesis</title><p>Gut microbiome is numerous, diverse, and dynamic. It is critical to determine its role in T1D predisposition and pathogenesis. However, the mechanism is very complicated and remains elusive so far. To our knowledge, gut microbiome may exert function by affecting intestinal permeability, molecular mimicry, and modulating innate and adaptive immune system.</p><sec id="dmrr3043-sec-0007"><label>2.4.1</label><title>Intestinal permeability</title><p>The intestinal barrier maintains mucosa permeability and separates the luminal antigens from the interior of the body. When intestinal barrier is disrupted, intestinal permeability may increase. Studies showed that when intestinal barrier is compromised, pancreatic&#x02010;draining lymph node T cells, particularly diabetogenic CD8+ T cells, would be activated and proliferate, promoting insulitis. It has been reported that intestinal permeability in children with T1D was significantly higher than that in controls.<xref rid="dmrr3043-bib-0056" ref-type="ref">56</xref> Maffeis and colleagues chose 10 healthy subjects and 10 children at risk for T1D to participate in a case&#x02010;control study to examine the relationship between intestinal permeability and T1D. The results showed that 3 bacteria, including <italic>Dialister invisus</italic>, <italic>Gemella sanguinis</italic>, and <italic>Bifidobacterium longum,</italic> were associated with altered intestinal permeability in T1D.<xref rid="dmrr3043-bib-0057" ref-type="ref">57</xref> In addition, many other studies revealed that the changes of certain microbes, such as <styled-content style="fixed-case"><styled-content style="italic-in-any-context">Clostridium perfringens</styled-content></styled-content>, <italic>Dialister invisus</italic>, <italic>Gemella sanguinis</italic>, and <italic>Bifidobacterium longum</italic>, were related to compromised gut integrity and increased T1D risk.<xref rid="dmrr3043-bib-0029" ref-type="ref">29</xref>, <xref rid="dmrr3043-bib-0048" ref-type="ref">48</xref>, <xref rid="dmrr3043-bib-0050" ref-type="ref">50</xref>, <xref rid="dmrr3043-bib-0057" ref-type="ref">57</xref> When the intestinal permeability is increased, intestinal toxins, food antigens, and infection factors may translocate from gastrointestinal lumen to intestinal mucosal components, and finally to the pancreatic lymph nodes to induce or exacerbate T1D.<xref rid="dmrr3043-bib-0029" ref-type="ref">29</xref>
</p></sec><sec id="dmrr3043-sec-0008"><label>2.4.2</label><title>Molecular mimicry</title><p>Considering the various and numerous bacteria in the gut, it is not easy to estimate the amount of bacterial proteins or metabolites produced. Of note, a number of bacterial proteins have been demonstrated to share the similar molecular structure with self&#x02010;antigen in pancreas. An illustration is Mgt protein of <italic>Leptotrichia goodfellowii</italic> and islet&#x02010;specific glucose&#x02010;6&#x02010;phosphatase&#x02010;related protein (IGRP). IGRP protein is a member of G6Pase family and specifically expressed in pancreas. IGRP<sub>206&#x02010;214</sub> peptide (VYLKTNVFL) is an important epitope that can activate diabetogenic NY8.3&#x000a0;T cells. <italic>Leptotrichia goodfellowii</italic> is a member of <italic>Fusobacteria</italic>. Interestingly, although <italic>Fusobacteria</italic> usually composes a small portion in the gut microbiome (&#x0003c;0.1%), it is closely related to autoimmune disease, inflammatory bowel diseases (IBDs), and skin ulcers.<xref rid="dmrr3043-bib-0058" ref-type="ref">58</xref>, <xref rid="dmrr3043-bib-0059" ref-type="ref">59</xref>, <xref rid="dmrr3043-bib-0060" ref-type="ref">60</xref>
</p><p>A fragment of Mgt protein in <italic>L. goodfellowii</italic> (267&#x02010;275, TYLKTNVFT) shares sequence similarity with IGRP<sub>206&#x02010;214</sub>. Experimentally, Mgt<sub>267&#x02010;275</sub> activated NY8.3&#x000a0;T cells and accelerated T1D in NOD mice. In addition to <italic>L. goodfellowii</italic>, <italic>Flavobacteriia</italic> bacterium, <italic>Bacillus cereus</italic>, and <italic>Enterobacter mori LMG 25706</italic> also possessed homologue peptides of IGRP<sub>206&#x02010;214</sub>, which were functional in vitro and in vivo.<xref rid="dmrr3043-bib-0043" ref-type="ref">43</xref> These findings illustrate that certain diabetogenic microbes exist in the gut and can induce or speed up the occurrence of T1D through molecular mimicry.</p><p>Notably, molecular mimicry is an important mechanism of gut microbiome not only for T1D but also for many other autoimmune diseases. Systemic lupus erythematosus is an autoimmune disease characterized by multi&#x02010;system damage. Unlike T1D, B cells and autoantibodies play an essential role in disease pathogenesis. Hevia and colleagues recruited 20 remission patients and matched healthy control. They found a lower <italic>Firmicutes</italic>/<italic>Bacteroidetes</italic> ratio in the gut microbes from Systemic lupus erythematosus patients, but the exact mechanism was not further studied.<xref rid="dmrr3043-bib-0061" ref-type="ref">61</xref> Following studies demonstrated that <styled-content style="fixed-case"><styled-content style="italic-in-any-context">B. fragilis</styled-content></styled-content>, a member of <italic>Bacteroides</italic> bacteria phylum, can recognize and stimulate VH4&#x02010;34&#x02010;encoded IgG+ autoreactive B cells.<xref rid="dmrr3043-bib-0062" ref-type="ref">62</xref> Interestingly, molecular mimicry does not always exacerbate autoimmune diseases. <italic>Bacteroides</italic> express integrase that contains a low&#x02010;avidity mimotope for IGRP<sub>206&#x02010;214.</sub> This mimotope helps to recruit diabetogenic CD8+ T cells to gut and further suppress IBD by targeting gut dendritic cells.<xref rid="dmrr3043-bib-0063" ref-type="ref">63</xref> Therefore, molecular mimicry generally is a very important mechanism for gut microbiome to induce autoimmune diseases, but its exact role may depend on different diseases and scenarios.</p></sec><sec id="dmrr3043-sec-0009"><label>2.4.3</label><title>Innate immune system</title><p>Multiple lymph cells infiltrate into the pancreas during early insulitis, including macrophages. Pancreatic macrophages reside in intra&#x02010;islet vessels and are in close contact with &#x003b2; cells.<xref rid="dmrr3043-bib-0064" ref-type="ref">64</xref> Pancreatic macrophages capture dense core and present islet granules to islet reactive CD4+ T cells, contributing to the destruction of &#x003b2; cells.<xref rid="dmrr3043-bib-0065" ref-type="ref">65</xref> Ferris and colleagues found that macrophages in NOD islets possessed an activated state, presenting with the elevated sensitivity to stimuli and increased expression of inflammatory transcripts, like Cxcl9, Ccl5, and Cd40. More importantly, injection of lipopolysaccharide (LPS), a layer of lipid polysaccharide in the outermost layer of gram negative bacteria, resulted in rapid inflammation in the pancreas, indicating that islet macrophages can sense and respond to gut microbiome and accelerate T1D.<xref rid="dmrr3043-bib-0064" ref-type="ref">64</xref>
</p><p>Gut microbiome possesses multiple pathogen&#x02010;associated molecular patterns, such as LPS, lipoproteins, peptidoglycan, and their nucleic acids. The reorganization of pathogen&#x02010;associated molecular patterns depends on pattern&#x02010;recognition receptors in the host, particularly toll&#x02010;like receptors.<xref rid="dmrr3043-bib-0066" ref-type="ref">66</xref> Gut microbes can trigger different toll&#x02010;like receptors to induce both pro&#x02010;diabetogenic and anti&#x02010;diabetogenic signals. Toll&#x02010;like receptor&#x02010;induced signals are mediated by signalling adaptors, such as MyD88, to promote cellular responses to LPS.<xref rid="dmrr3043-bib-0067" ref-type="ref">67</xref>, <xref rid="dmrr3043-bib-0068" ref-type="ref">68</xref> Myeloid differentiation primary response gene88&#x02013;deficient NOD mice in SPF environment were protected from diabetes. Surprisingly, T1D was developed in the GF Myd88&#x02010;negative NOD mice, indicating that the T1D&#x02010;protective effect required signals from gut microbiome.<xref rid="dmrr3043-bib-0069" ref-type="ref">69</xref>
</p></sec><sec id="dmrr3043-sec-0010"><label>2.4.4</label><title>Adaptive immune system</title><p>In addition to innate immunity, the interaction between gut microbes and adaptive immunity is essential for the development and pathogenesis of T1D. Some particular gut bacteria have the capacity to regulate T cell subsets and function. <italic>Listeria</italic> can induce Th1 response, and segmented filamentous bacteria can augment Th17 responses. The altered schaedler flora and consortia of Clostridia have the capability to induce regulatory T cells.<xref rid="dmrr3043-bib-0070" ref-type="ref">70</xref>, <xref rid="dmrr3043-bib-0071" ref-type="ref">71</xref> Furthermore, altered gut microflora can increase the number of type 1 regulatory T (Tr1) cells in the intestine. These Tr1 cells can migrate into the periphery, inhibiting the activation of effector T cells and decreasing diabetes incidence.<xref rid="dmrr3043-bib-0072" ref-type="ref">72</xref>
</p><p>So far the exact mechanism for the bacteria mentioned above to promote the differentiation of na&#x000ef;ve T cells into different helper T cells is largely unknown. Short&#x02010;chain fatty acids, which are secreted by gut microbes, have been proved to exert an important role. Short&#x02010;chain fatty acids, including acetate, propionate, and butyrate, are produced by bacterial fermentation of cellulose that cannot be digested by host enzymes.<xref rid="dmrr3043-bib-0073" ref-type="ref">73</xref> Short&#x02010;chain fatty acids may support epithelial cell integrity as well as the function of adaptive immune cells (e.g., promoting peripheral regulatory T&#x02010;cell generation).<xref rid="dmrr3043-bib-0074" ref-type="ref">74</xref>, <xref rid="dmrr3043-bib-0075" ref-type="ref">75</xref> Mari&#x000f1;o and colleagues reported that mice dieted with acetate and butyrate were protected from T1D. They further demonstrated that acetate markedly decreased the frequency of autoreactive T cells in lymphoid tissues and butyrate increased the number and function of regulatory T cells. Acetate and butyrate also maintained intestinal integrity and decreased the concentration of diabetogenic cytokines in the serum, like IL&#x02010;21.<xref rid="dmrr3043-bib-0076" ref-type="ref">76</xref> As mentioned earlier, SPF rather than GF Myd88 negative NOD mice showed delayed onset of T1D. Correspondingly, the concentration of acetate and butyrate in the serum of SPF Myd88 deficient NOD mice was much higher when compared with those in GF transgenic NOD mice. To further explore the potential mechanism, GF Myd88&#x02010;deficient NOD mice were fed with acetate or butyrate for 5&#x000a0;weeks. The reduced frequency of autoreactive T cells and the increased number of Treg cells were found in the spleen and colon, suggesting that SCFAs produced by gut microbes are essential in disease protection.<xref rid="dmrr3043-bib-0076" ref-type="ref">76</xref>
<styled-content style="fixed-case"><styled-content style="italic-in-any-context">Bacteroides fragilis</styled-content></styled-content> could induce Treg cells and enhance its suppressive function, which also required butyrate.<xref rid="dmrr3043-bib-0077" ref-type="ref">77</xref>, <xref rid="dmrr3043-bib-0078" ref-type="ref">78</xref>
</p><p>In addition to T cells, SCFAs are able to influence B cell activity.<xref rid="dmrr3043-bib-0079" ref-type="ref">79</xref> Recently, Kim and colleagues demonstrated that SCFAs regulated the energy metabolism of B cells in the gut, and promoted B cells differentiating into plasma cells and memory B cells through BCR&#x02010;activating antigens, resulting in more IgG and IgA production.<xref rid="dmrr3043-bib-0080" ref-type="ref">80</xref>, <xref rid="dmrr3043-bib-0081" ref-type="ref">81</xref> Meanwhile, IgA can coat a substantial amount of gut microbes to protect from exotic pathogens and maintain the homeostasis of the intestine. This is essential for bacteria colonization in the gut of neonates. Therefore, IgA can be used as a marker for colonization of gut microbiome.<xref rid="dmrr3043-bib-0070" ref-type="ref">70</xref>
</p></sec></sec></sec><sec id="dmrr3043-sec-0011"><label>3</label><title>GUT MICROBIOME AS A BIOMARKER FOR T1D</title><p>We have shown that gut microbiome is closely related to the occurrence and development of T1D. As mentioned earlier, the composition of intestinal microflora is altered before the onset of T1D, including a reduced microbial diversity and increased <italic>Bacteriodetes in</italic> subjects with pre&#x02010;T1D.<xref rid="dmrr3043-bib-0009" ref-type="ref">9</xref> Specifically, the abundance of <italic>B.dorei</italic> in <italic>Bacteriodetes</italic> is increased and can be a useful predictor for T1D in Finland. Furthermore, those <italic>Bacteroides</italic> strains are resistant to common antibiotics and correlated with high&#x02010;protein and high&#x02010;fat diets.<xref rid="dmrr3043-bib-0046" ref-type="ref">46</xref> However, an important issue is that the composition of gut microbes largely depends on environmental factors (e.g., geographic location, eating habits, and sanitary conditions). Therefore, the results found in Finland may not be able to apply to other geographical locations. In addition, we need to evaluate the advantage of gut microbiome in T1D prediction, when compared with islet autoantibodies that have already been used in the clinical practice to predict T1D. The value of gut microbiome in T1D prediction requires further studies.</p></sec><sec id="dmrr3043-sec-0012"><label>4</label><title>T1D TREATMENT AND GUT MICROBIOME</title><p>Besides disease prediction, the application of gut microbiome to treat T1D seems promising. In animals, the incidence of T1D in disease&#x02010;prone mice could be dramatically reduced when cohorting with normal mice or orally gavage with faecal samples from healthy mice.<xref rid="dmrr3043-bib-0043" ref-type="ref">43</xref> Oral probiotic administration could also prevent diabetes development in NOD mice.<xref rid="dmrr3043-bib-0082" ref-type="ref">82</xref> Interestingly, a recent study reported that accurate regulation of gut microbiome by using tungstate, which could specifically inhibit molybdenum&#x02010;cofactor&#x02010;dependent microbial respiratory pathways, relieved IBD with minimal side effects.<xref rid="dmrr3043-bib-0083" ref-type="ref">83</xref> The transformation or precision editing of gut microbiome may be applied to treat T1D in the future. In humans, several clinical trials using probiotics to treat T1D are undergoing, which are summarized in Table&#x000a0;<xref rid="dmrr3043-tbl-0002" ref-type="table">2</xref>.</p><table-wrap id="dmrr3043-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>The summary of gut microbiome in clinical trials of type 1 diabetes</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">NCT No.</th><th align="left" valign="bottom" rowspan="1" colspan="1">Trial Name</th><th align="left" valign="bottom" rowspan="1" colspan="1">Interventions</th><th align="left" valign="bottom" rowspan="1" colspan="1">Intervention Model</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outcome Measures</th><th align="left" valign="bottom" rowspan="1" colspan="1">Estimated Enrollment</th><th align="left" valign="bottom" rowspan="1" colspan="1">Sponsors</th><th align="left" valign="bottom" rowspan="1" colspan="1">Status</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">NCT03423589</td><td align="left" valign="top" rowspan="1" colspan="1">Modulation of type 1 diabetes susceptibility through the use of probiotics</td><td align="left" valign="top" rowspan="1" colspan="1">VSL#3</td><td align="left" valign="top" rowspan="1" colspan="1">Single group assignment</td><td align="left" valign="top" rowspan="1" colspan="1">Transcriptional analysis, gut microbiota</td><td align="center" valign="top" rowspan="1" colspan="1">30 participants</td><td align="left" valign="top" rowspan="1" colspan="1">Medical College of Wisconsin</td><td align="left" valign="top" rowspan="1" colspan="1">Recruiting</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCT02903615</td><td align="left" valign="top" rowspan="1" colspan="1">Optimizing health in type 1 diabetes</td><td align="left" valign="top" rowspan="1" colspan="1">Novel diet: Prebiotic fibre focus, lower carbohydrate, Mediterranean&#x02010;style. Standard diet</td><td align="left" valign="top" rowspan="1" colspan="1">Parallel assignment</td><td align="left" valign="top" rowspan="1" colspan="1">Glucose control</td><td align="center" valign="top" rowspan="1" colspan="1">20 participants</td><td align="left" valign="top" rowspan="1" colspan="1">Garvan Institute of Medical Research</td><td align="left" valign="top" rowspan="1" colspan="1">Recruiting</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCT02605148</td><td align="left" valign="top" rowspan="1" colspan="1">TEFA family prevention: Gluten&#x02010;free diet to preserve Beta&#x02010;cell function (TEFA)</td><td align="left" valign="top" rowspan="1" colspan="1">Gluten free diet with probiotics, omega 3 fatty acid, vitamin D supplement</td><td align="left" valign="top" rowspan="1" colspan="1">Parallel assignment</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b2;&#x02010;cell function, glucose control</td><td align="center" valign="top" rowspan="1" colspan="1">60 participants</td><td align="left" valign="top" rowspan="1" colspan="1">Lund University</td><td align="left" valign="top" rowspan="1" colspan="1">Recruiting</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCT02442544</td><td align="left" valign="top" rowspan="1" colspan="1">Prebiotic fibre supplement in T1DM children</td><td align="left" valign="top" rowspan="1" colspan="1">
Prebiotic,<break/>
Placebo</td><td align="left" valign="top" rowspan="1" colspan="1">Parallel assignment</td><td align="left" valign="top" rowspan="1" colspan="1">Glucose control, gut microbiota</td><td align="center" valign="top" rowspan="1" colspan="1">38 participants</td><td align="left" valign="top" rowspan="1" colspan="1">University of Calgary</td><td align="left" valign="top" rowspan="1" colspan="1">Active, not recruiting</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCT03032354</td><td align="left" valign="top" rowspan="1" colspan="1">Probiotics in newly recognized type 1 diabetes</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Lactobacillus rhamnosus</italic> GG and Bifidobacterium lactis BB12, placebo</td><td align="left" valign="top" rowspan="1" colspan="1">Parallel assignment</td><td align="left" valign="top" rowspan="1" colspan="1">&#x003b2;&#x02010;cell function</td><td align="center" valign="top" rowspan="1" colspan="1">96 participants</td><td align="left" valign="top" rowspan="1" colspan="1">
Medical University of Warsaw</td><td align="left" valign="top" rowspan="1" colspan="1">Active, not recruiting</td></tr></tbody></table></table-wrap><p>The modulation of gut microbiome may be a valuable approach for T1D treatment. Nevertheless, T1D treatment with drugs might affect gut microbiome the other way round. Currently, insulin is commonly used for glycemic control in T1D patients, while certain immunomodulators and traditional Chinese medicine are in the pre&#x02010;clinical or clinical trials. Their effects on gut microbiome are discussed below.</p><sec id="dmrr3043-sec-0013"><label>4.1</label><title>Insulin</title><p>The previous literature showed that several drugs commonly used in the treatment of type 2 diabetes, such as metformin, liraglutide, and saxagliptin, had an impact on the composition of gut microbiome.<xref rid="dmrr3043-bib-0084" ref-type="ref">84</xref>, <xref rid="dmrr3043-bib-0085" ref-type="ref">85</xref> Insulin administration is commonly used in patients with T1D, but whether insulin treatment can affect gut microbiome is still unknown. A recent article investigated it by using the NOD mouse model. From 4 to 9&#x000a0;weeks of age, mice were given by gavage porcine insulin twice a week, followed by once a week of insulin for 21&#x000a0;weeks. Faeces were collected and gut microflora composition was determined by 16&#x000a0;s RNA sequencing. As a result, they found that oral insulin administration had no effect on gut microbiota.<xref rid="dmrr3043-bib-0086" ref-type="ref">86</xref> The possible reason could be that most of insulin was degraded when it passed through the intestine, causing its low bioavailability. However, in clinical practice, insulin is commonly subcutaneously injected in T1D patients. So far, whether insulin administration can affect gut microbiome in T1D patients has not been reported yet.</p></sec><sec id="dmrr3043-sec-0014"><label>4.2</label><title>Immunomodulators</title><p>Since T1D is an autoimmune disease, several immunomodulators were accessed for their potential in T1D immunotherapy. Among those, the anti&#x02010;CD20 chimeric mAb (rituxizumab that depletes most of B cells), the humanized anti&#x02010;CD3 mAbs (teplizumab and otelixizumab), glutamic acid decarboxylase 65 (to induce antigen specific tolerance), DiaPep277 (the peptide corresponding to the human heat shock protein 60<sub>437&#x02013;460</sub>), and abatacept (CTLA&#x02010;4&#x02010;Ig fusion protein that inhibits T cell activation) have been evaluated in clinical trials.<xref rid="dmrr3043-bib-0087" ref-type="ref">87</xref>, <xref rid="dmrr3043-bib-0088" ref-type="ref">88</xref>, <xref rid="dmrr3043-bib-0089" ref-type="ref">89</xref>, <xref rid="dmrr3043-bib-0090" ref-type="ref">90</xref>, <xref rid="dmrr3043-bib-0091" ref-type="ref">91</xref>, <xref rid="dmrr3043-bib-0092" ref-type="ref">92</xref> Although most of immunomodulators showed only modest success in clinical studies, their effects on gut microbiome have not been known yet.</p><p>In mouse models, several studies suggest that certain immunomodulators can alter gut microbiome. In allogeneic skin graft mouse, teplizumab administration protected against disease by increasing IL&#x02010;10&#x02013;producing T cells. Interestingly, those T cells were required to migrate into the intestine to exert the protective function. If the migration was blocked, the treatment effects of teplizumab were abolished, indicating that gut microbiome might be involved in teplizumab&#x02010;mediated disease protection.<xref rid="dmrr3043-bib-0093" ref-type="ref">93</xref> The following study found that alteration of gut microbiome during anti&#x02010;CD3 mAb treatment or cohousing experiments significantly boosted intestinal IL&#x02010;10&#x02013;producing Tr1 cells and decrease T1D incidence.<xref rid="dmrr3043-bib-0072" ref-type="ref">72</xref> Further studies may be required to clarify how gut microbiome is altered after anti&#x02010;CD3 mAb treatment.</p></sec><sec id="dmrr3043-sec-0015"><label>4.3</label><title>Traditional Chinese medicine</title><p>Traditional Chinese medicine, also called herbal medicine (HM), has been used in worldwide for a thousand years. Most HMs are taken orally, which may preferentially alter gut microflora. An interplay between HMs and gut microbes might exist. On one hand, gut bacteria play an essential role in HM therapy by biotransforming HM chemicals into effective smaller units that can be better absorbed.<xref rid="dmrr3043-bib-0046" ref-type="ref">46</xref> On the other hand, HM chemicals improve the composition of intestinal flora and pathological condition. So far, most HMs have not been studied in T1D yet, except very few reports. Ganoderma lucidum could drop the increased <italic>Firmicutes</italic>/<italic>Bacteriodetes</italic> ratio to normal level.<xref rid="dmrr3043-bib-0094" ref-type="ref">94</xref> Berberine, a plant benzylisoquinoline alkaloid, showed the capability to protect NOD mice from T1D by modulating immune system.<xref rid="dmrr3043-bib-0053" ref-type="ref">53</xref> Artemisinin and Danzhi Jiangtang Capsule could improve the function islet &#x003b2; cells by increasing &#x003b2;&#x02010;cell mass and reducing pancreatic &#x003b2;&#x02010;cell apoptosis, respectively.<xref rid="dmrr3043-bib-0095" ref-type="ref">95</xref>, <xref rid="dmrr3043-bib-0096" ref-type="ref">96</xref> However, whether and how gut microbiome is altered in HMs&#x02010;mediated disease protection is unknown yet<bold>.</bold>
</p></sec></sec><sec id="dmrr3043-sec-0016"><label>5</label><title>CONCLUSION AND PERSPECTIVE</title><p>Currently, the role and mechanism of gut microbiome in T1D attract more and more attention. A rapid growing number of publications have been reported in recent years. Although great progress has been made, many details are still missing and a large number of questions need to be answered.</p><p>Genome&#x02010;wide association studies have identified more than 50 T1D&#x02010;related susceptibility genes. Among them, HLA genes contribute to disease susceptibility substantially in both humans and NOD mice. Replacement of NOD IA&#x02010;g7 with C57BL/6 E&#x003b1;16 prevented T1D in transgenic NOD mice, because of the altered antigen presentation for islet autoantigens. However, a recent article reported that the disease protection in E&#x003b1;16/NOD mice also depended on gut microbiome, illustrated by the fact that GF or antibiotics&#x02010;treated E&#x003b1;16/NOD lost the disease protection. These data indicate that an interplay between T1D susceptibility genes and gut microbiome may exist and play a crucial role in the pathogenesis of T1D.<xref rid="dmrr3043-bib-0097" ref-type="ref">97</xref>
</p><p>Notably, many susceptibility genes (e.g., IL&#x02010;10, IFIH1, TNFAIP3, PTPN2, and FUT2) are shared between T1D and IBD.<xref rid="dmrr3043-bib-0098" ref-type="ref">98</xref>, <xref rid="dmrr3043-bib-0099" ref-type="ref">99</xref> Whether those genes have an impact on gut microflora in T1D is unknown. If the impact exists, how to establish the link between susceptibility genes, altered gut bacteria, and T1D pathology requires further studies.</p><p>To sum up, T1D is an autoimmune disease triggered by both genetic and environmental factors. In past decades, a substantial progression has been made to clarify the genetics risk factors by using genome&#x02010;wide association studies. But genetics alone is not sufficient to explain why the prevalence of T1D increases at a rate of 3% to 5% per year, when considering genetics in population to be relatively stable. In recent years, the importance of environmental factors in T1D, especially gut microbiome, has been realized. Growing attention has been paid to clarify the taxonomic and functional changes of gut microbiome in the disease pathogenesis, and the interplay between gut microbiome with immune system, which is becoming the hotspot of both research and clinical trials in the field.</p><p>Gut microbiome, especially SCFAs, are important to maintain intestinal barrier and immune homeostasis. Evidence so far has demonstrated that dysbiosis of gut microbiome increases T1D predisposition. In humans or animals, the decreased diversity of gut microbiome occurs before disease onset and remains after the diagnosis of T1D. <italic>Bacteroidetes</italic> and <italic>Firmicutes</italic> are dominant in the faecal samples. The ratio of <italic>Firmicutes</italic> to <italic>Bacteroidetes</italic> is decreased in T1D patients. <italic>Dialister invisus</italic>, <italic>Gemella sanguinis</italic>, and <italic>Bifidobacterium longum</italic> are associated with intestinal permeability. Once the balance of gut microflora is disrupted, the compromised intestinal mucosa permeability may lead to outer or bacterial antigen leakage, boosting excessive immune response or activating autoreactive T cells by molecular mimicry (Figure&#x000a0;<xref rid="dmrr3043-fig-0001" ref-type="fig">1</xref>).</p><fig fig-type="Figure" xml:lang="en" id="dmrr3043-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The role of gut microbiome in type 1 diabetes. Multiple factors can influence gut microbiome, resulting in an increase in intestinal permeability, a decrease in gut microbiome diversity, and <italic>Firmicutes</italic>/<italic>Bacteroidetes</italic> ratio. Consequently, these changes may destroy islet &#x003b2; cells through molecular mimicry, excessive activation of innate immunity, and adaptive immunity</p></caption><graphic id="nlm-graphic-1" xlink:href="DMRR-34-na-g001"/></fig><p>In light of these results, gut microbiome may be a critical modulator in T1D predisposition and pathogenesis. Continuous studies are required to obtain a better understanding on the roles and mechanisms of gut microbiome in T1D, which may provide a valuable tool to predict and treat T1D in the future.</p></sec><sec id="dmrr3043-sec-0018"><title>CONFLICT OF INTEREST</title><p>Authors Zheng P, Li Z, and Zhou Z declare that they have no conflict of interest.</p></sec><sec id="dmrr3043-sec-0019"><title>ETHICAL APPROVAL</title><p>This review article cites the peer&#x02010;reviewed articles of our group and other groups. Therefore, the study designs are detailed in the primary articles, and this review does not include a study design with the direct ethical statements of the human study or animal study designs. For our own published studies cited in this article, all animal studies go through the office of human studies or the animal studies offices to confirm the ethical treatment of humans and animals in research.</p></sec></body><back><ack id="dmrr3043-sec-0017"><title>ACKNOWLEDGEMENTS</title><p>We thank Ms Yani Peng for language embellishment of the manuscript. This work is supported by the National Natural Science Foundation of China (grant no. 81500600, 81670716, and 81461168031), the National Science and Technology Infrastructure Program (2015BAI12B13), and the Graduate innovation project of Central South University (grant no. 502211703).</p></ack><ref-list id="dmrr3043-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="dmrr3043-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0002">
<string-name>
<surname>Boldison</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>FS</given-names>
</string-name>. <article-title>Immune and pancreatic beta cell interactions in type 1 diabetes</article-title>. <source xml:lang="en">Trends Endocrinol Metab</source>. <year>2016</year>;<volume>27</volume>(<issue>12</issue>):<fpage>856</fpage>&#x02010;<lpage>867</lpage>.<pub-id pub-id-type="pmid">27659143</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0003">
<string-name>
<surname>Yi</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>ZG</given-names>
</string-name>. <article-title>Current and future clinical applications of zinc transporter&#x02010;8 in type 1 diabetes mellitus</article-title>. <source xml:lang="en">Chin Med J (Engl)</source>. <year>2015</year>;<volume>128</volume>(<issue>17</issue>):<fpage>2387</fpage>&#x02010;<lpage>2394</lpage>.<pub-id pub-id-type="pmid">26315089</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0004">
<string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese</article-title>. <source xml:lang="en">Diabetes Metab Res Rev</source>. <year>2010</year>;<volume>26</volume>(<issue>7</issue>):<fpage>579</fpage>&#x02010;<lpage>584</lpage>.<pub-id pub-id-type="pmid">20842762</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0005">
<string-name>
<surname>Chao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acute&#x02010;onset type 1 diabetes mellitus</article-title>. <source xml:lang="en">Chin Med J (Engl)</source>. <year>2013</year>;<volume>126</volume>(<issue>21</issue>):<fpage>4006</fpage>&#x02010;<lpage>4012</lpage>.<pub-id pub-id-type="pmid">24229665</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0006">
<string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>Q</given-names>
</string-name>, et al. <article-title>Beyond genetics: what causes type 1 diabetes</article-title>. <source xml:lang="en">Clinic Rev Allerg Immunol</source>. <year>2016</year>;<volume>52</volume>(<issue>2</issue>):<fpage>273</fpage>&#x02010;<lpage>584</lpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0007">
<string-name>
<surname>Amur</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Parekh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mummaneni</surname>
<given-names>P</given-names>
</string-name>. <article-title>Sex differences and genomics in autoimmune diseases</article-title>. <source xml:lang="en">J Autoimmun</source>. <year>2012</year>;<volume>38</volume>:<fpage>254</fpage>&#x02010;<lpage>265</lpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0008">
<string-name>
<surname>Beeson</surname>
<given-names>PB</given-names>
</string-name>. <article-title>Age and sex associations of 40 autoimmune diseases</article-title>. <source xml:lang="en">Am J Med</source>. <year>1994</year>;<volume>96</volume>(<issue>5</issue>):<fpage>457</fpage>&#x02010;<lpage>462</lpage>.<pub-id pub-id-type="pmid">8192178</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0009">
<string-name>
<surname>Yurkovetskiy</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Burrows</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>AA</given-names>
</string-name>, et al. <article-title>Gender bias in autoimmunity is influenced by microbiota</article-title>. <source xml:lang="en">Immunity</source>. <year>2013</year>;<volume>39</volume>(<issue>2</issue>):<fpage>400</fpage>&#x02010;<lpage>412</lpage>.<pub-id pub-id-type="pmid">23973225</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0010">
<string-name>
<surname>G&#x000fc;lden</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>L</given-names>
</string-name>. <article-title>The gut microbiota and type 1 diabetes</article-title>. <source xml:lang="en">Clin Immunol</source>. <year>2015</year>;<volume>159</volume>(<issue>2</issue>):<fpage>143</fpage>&#x02010;<lpage>153</lpage>.<pub-id pub-id-type="pmid">26051037</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0011">
<string-name>
<surname>Pociot</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>McDermott</surname>
<given-names>MF</given-names>
</string-name>. <article-title>Genetics of type 1 diabetes mellitus</article-title>. <source xml:lang="en">Genes Immun</source>. <year>2002</year>;<volume>3</volume>(<issue>5</issue>):<fpage>235</fpage>&#x02010;<lpage>249</lpage>.<pub-id pub-id-type="pmid">12140742</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0012">
<string-name>
<surname>Ziegler</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Nepom</surname>
<given-names>GT</given-names>
</string-name>. <article-title>Prediction and pathogenesis in type 1 diabetes</article-title>. <source xml:lang="en">Immunity</source>. <year>2010</year>;<volume>32</volume>(<issue>4</issue>):<fpage>468</fpage>&#x02010;<lpage>478</lpage>.<pub-id pub-id-type="pmid">20412757</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0013">
<string-name>
<surname>van Belle</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Coppieters</surname>
<given-names>KT</given-names>
</string-name>, <string-name>
<surname>Coppieters</surname>
<given-names>MG</given-names>
</string-name>. <article-title>Type 1 diabetes: etiology, immunology, and therapeutic strategies</article-title>. <source xml:lang="en">Physiol Rev</source>. <year>2011</year>;<volume>91</volume>(<issue>1</issue>):<fpage>79</fpage>&#x02010;<lpage>118</lpage>.<pub-id pub-id-type="pmid">21248163</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0014">
<string-name>
<surname>Zheng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kissler</surname>
<given-names>S</given-names>
</string-name>. <article-title>PTPN22 silencing in the NOD model indicates the type 1 diabetes&#x02010;associated allele is not a loss&#x02010;of&#x02010;function variant</article-title>. <source xml:lang="en">Diabetes</source>. <year>2013</year>;<volume>62</volume>(<issue>3</issue>):<fpage>896</fpage>&#x02010;<lpage>904</lpage>.<pub-id pub-id-type="pmid">23193190</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0015">
<string-name>
<surname>Xie</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Molecular mechanisms in autoimmune type 1 diabetes: a critical review</article-title>. <source xml:lang="en">Clin Rev Allergy Immunol</source>. <year>2014</year>;<volume>47</volume>(<issue>2</issue>):<fpage>174</fpage>&#x02010;<lpage>192</lpage>.<pub-id pub-id-type="pmid">24752371</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0016">
<string-name>
<surname>Knip</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Siljander</surname>
<given-names>H</given-names>
</string-name>. <article-title>The role of the intestinal microbiota in type 1 diabetes mellitus</article-title>. <source xml:lang="en">Nat Rev Endocrinol</source>. <year>2016</year>;<volume>12</volume>(<issue>3</issue>):<fpage>154</fpage>&#x02010;<lpage>167</lpage>.<pub-id pub-id-type="pmid">26729037</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0017">
<string-name>
<surname>Knip</surname>
<given-names>M</given-names>
</string-name>. <article-title>Environmental triggers and determinants of beta&#x02010;cell autoimmunity and type 1 diabetes</article-title>. <source xml:lang="en">Rev Endocr Metab Disord</source>. <year>2003</year>;<volume>4</volume>(<issue>3</issue>):<fpage>213</fpage>&#x02010;<lpage>223</lpage>.<pub-id pub-id-type="pmid">14501172</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0018">
<string-name>
<surname>Kaufman</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Erlander</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Clare&#x02010;Salzler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Atkinson</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Maclaren</surname>
<given-names>NK</given-names>
</string-name>, <string-name>
<surname>Tobin</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Autoimmunity to two forms of glutamate decarboxylase in insulin&#x02010;dependent diabetes mellitus</article-title>. <source xml:lang="en">J Clin Invest</source>. <year>1992</year>;<volume>89</volume>(<issue>1</issue>):<fpage>283</fpage>&#x02010;<lpage>292</lpage>.<pub-id pub-id-type="pmid">1370298</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0019">
<string-name>
<surname>Yoon</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Onodera</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Notkins</surname>
<given-names>AL</given-names>
</string-name>. <article-title>Virus&#x02010;induced diabetes mellitus. XV. Beta cell damage and insulin&#x02010;dependent hyperglycemia in mice infected with coxsackie virus B4</article-title>. <source xml:lang="en">J Exp Med</source>. <year>1978</year>;<volume>148</volume>(<issue>4</issue>):<fpage>1068</fpage>&#x02010;<lpage>1080</lpage>.<pub-id pub-id-type="pmid">212506</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0020">
<string-name>
<surname>Luopajarvi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Savilahti</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Virtanen</surname>
<given-names>SM</given-names>
</string-name>, et al. <article-title>Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood</article-title>. <source xml:lang="en">Pediatr Diabetes</source>. <year>2008</year>;<volume>9</volume>(<issue>5</issue>):<fpage>434</fpage>&#x02010;<lpage>441</lpage>.<pub-id pub-id-type="pmid">18503496</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0021">
<string-name>
<surname>Du</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>You</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Regulation by 1, 25&#x02010;dihydroxy&#x02010;vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes</article-title>. <source xml:lang="en">Clin Chim Acta</source>. <year>2009</year>;<volume>402</volume>(<issue>1&#x02010;2</issue>):<fpage>133</fpage>&#x02010;<lpage>138</lpage>.<pub-id pub-id-type="pmid">19210958</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0022">
<string-name>
<surname>Ghazarian</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Diana</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Simoni</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Beaudoin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lehuen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Prevention or acceleration of type 1 diabetes by viruses</article-title>. <source xml:lang="en">Cell Mol Life Sci</source>. <year>2013</year>;<volume>70</volume>(<issue>2</issue>):<fpage>239</fpage>&#x02010;<lpage>255</lpage>.<pub-id pub-id-type="pmid">22766971</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0023">
<string-name>
<surname>Candon</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Perez&#x02010;Arroyo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Marquet</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin&#x02010;dependent diabetes</article-title>. <source xml:lang="en">PLoS One</source>. <year>2015</year>;<volume>10</volume>:<elocation-id>e125448</elocation-id>.</mixed-citation></ref><ref id="dmrr3043-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0024">
<string-name>
<surname>Brugman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Klatter</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Visser</surname>
<given-names>JT</given-names>
</string-name>, et al. <article-title>Antibiotic treatment partially protects against type 1 diabetes in the bio&#x02010;breeding diabetes&#x02010;prone rat. Is the gut flora involved in the development of type 1 diabetes?</article-title>
<source xml:lang="en">Diabetologia</source>. <year>2006</year>;<volume>49</volume>(<issue>9</issue>):<fpage>2105</fpage>&#x02010;<lpage>2108</lpage>.<pub-id pub-id-type="pmid">16816951</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0025">
<string-name>
<surname>Hansen</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Krych</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>DS</given-names>
</string-name>, et al. <article-title>Early life treatment with vancomycin propagates <italic>Akkermansia muciniphila</italic> and reduces diabetes incidence in the NOD mouse</article-title>. <source xml:lang="en">Diabetologia</source>. <year>2012</year>;<volume>55</volume>(<issue>8</issue>):<fpage>2285</fpage>&#x02010;<lpage>2294</lpage>.<pub-id pub-id-type="pmid">22572803</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0026">
<string-name>
<surname>Mikkelsen</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Knop</surname>
<given-names>FK</given-names>
</string-name>, <string-name>
<surname>Vilsb&#x000f8;ll</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Frost</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hallas</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Potteg&#x000e5;rd</surname>
<given-names>A</given-names>
</string-name>. <article-title>Use of antibiotics in childhood and risk of type 1 diabetes: a population&#x02010;based case&#x02010;control study</article-title>. <source xml:lang="en">Diabet Med</source>. <year>2017</year>;<volume>34</volume>(<issue>2</issue>):<fpage>272</fpage>&#x02010;<lpage>277</lpage>.<pub-id pub-id-type="pmid">27646695</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0027">
<string-name>
<surname>Hooper</surname>
<given-names>LV</given-names>
</string-name>, <string-name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</string-name>. <article-title>Commensal host&#x02010;bacterial relationships in the gut</article-title>. <source xml:lang="en">Science</source>. <volume>292</volume>(<issue>5519</issue>):<fpage>1115</fpage>&#x02010;<lpage>1118</lpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0028">
<string-name>
<surname>Consortium</surname>
<given-names>HMP</given-names>
</string-name>. <article-title>Structure, function and diversity of the healthy human microbiome</article-title>. <source xml:lang="en">Nature</source>. <year>2012</year>;<volume>486</volume>:<fpage>207</fpage>&#x02010;<lpage>214</lpage>.<pub-id pub-id-type="pmid">22699609</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0029">
<string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tai</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Maternal antibiotic treatment protects offspring from diabetes development in nonobese diabetic mice by generation of tolerogenic APCs</article-title>. <source xml:lang="en">J Immunol</source>. <year>2015</year>;<volume>195</volume>(<issue>9</issue>):<fpage>4176</fpage>&#x02010;<lpage>4184</lpage>.<pub-id pub-id-type="pmid">26401004</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0030">
<string-name>
<surname>Bibb&#x000f2;</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dore</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Pes</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Delitala</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Delitala</surname>
<given-names>AP</given-names>
</string-name>. <article-title>Is there a role for gut microbiota in type 1 diabetes pathogenesis?</article-title>
<source xml:lang="en">Ann Med</source>. <year>2017</year>;<volume>49</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02010;<lpage>22</lpage>.<pub-id pub-id-type="pmid">27499366</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0031">
<string-name>
<surname>Hidalgo&#x02010;Cantabrana</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Delgado</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ruiz</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ruas&#x02010;Madiedo</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>S&#x000e1;nchez</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Margolles</surname>
<given-names>A</given-names>
</string-name>. <article-title>
<italic>Bifidobacteria</italic> and their health&#x02010;promoting effects</article-title>. <source xml:lang="en">Microbiol Spectr</source>. <year>2017</year>;<volume>5</volume>(<issue>3</issue>).</mixed-citation></ref><ref id="dmrr3043-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0032">
<string-name>
<surname>Samantha</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Whiteside</surname>
<given-names>HRSD</given-names>
</string-name>. <article-title>The microbiome of the urinary tract&#x02014;a role beyond infection</article-title>. <source xml:lang="en">Nat Rev Urol</source>. <year>2015</year>;<volume>12</volume>:<fpage>81</fpage>&#x02010;<lpage>90</lpage>.<pub-id pub-id-type="pmid">25600098</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0033">
<string-name>
<surname>Dominguez&#x02010;Bello</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Costello</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Contreras</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>26</issue>):<fpage>11971</fpage>&#x02010;<lpage>11975</lpage>.<pub-id pub-id-type="pmid">20566857</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0034">
<string-name>
<surname>Biasucci</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Benenati</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Morelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bessi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Boehm</surname>
<given-names>&#x00047;&#x00308;</given-names>
</string-name>. <article-title>Cesarean delivery may affect the early biodiversity of intestinal bacteria</article-title>. <source xml:lang="en">J Nutr</source>. <year>2008</year>;<volume>138</volume>(<issue>9</issue>):<fpage>1796S</fpage>&#x02010;<lpage>1800S</lpage>.<pub-id pub-id-type="pmid">18716189</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0035">
<string-name>
<surname>Brown</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>DeCoffe</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Molcan</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>DL</given-names>
</string-name>. <article-title>Diet&#x02010;induced Dysbiosis of the intestinal microbiota and the effects on immunity and disease</article-title>. <source xml:lang="en">Nutrients</source>. <year>2012</year>;<volume>4</volume>(<issue>8</issue>):<fpage>1095</fpage>&#x02010;<lpage>1119</lpage>.<pub-id pub-id-type="pmid">23016134</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0036">
<string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>L</given-names>
</string-name>. <article-title>Antibiotics, gut microbiota, environment in early life and type 1 diabetes</article-title>. <source xml:lang="en">Pharmacol Res</source>. <year>2017</year>;<volume>119</volume>:<fpage>219</fpage>&#x02010;<lpage>226</lpage>.<pub-id pub-id-type="pmid">28188825</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0037">
<string-name>
<surname>Geach</surname>
<given-names>T</given-names>
</string-name>. <article-title>Gut microbiota: Antibiotics do not affect metabolism in obesity</article-title>. <source xml:lang="en">Nat Rev Endocrinol</source>. <year>2016</year>;<volume>12</volume>:<fpage>558</fpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0038">
<string-name>
<surname>Jackson</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Goodrich</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Maxan</surname>
<given-names>ME</given-names>
</string-name>, et al. <article-title>Proton pump inhibitors alter the composition of the gut microbiota</article-title>. <source xml:lang="en">Gut</source>. <year>2016</year>;<volume>65</volume>(<issue>5</issue>):<fpage>749</fpage>&#x02010;<lpage>756</lpage>.<pub-id pub-id-type="pmid">26719299</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0039">
<string-name>
<surname>Sofi</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Gudi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Karumuthil&#x02010;Melethil</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Perez</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Vasu</surname>
<given-names>C</given-names>
</string-name>. <article-title>pH of drinking water influences the composition of gut microbiome and type 1 diabetes incidence</article-title>. <source xml:lang="en">Diabetes</source>. <year>2014</year>;<volume>63</volume>(<issue>2</issue>):<fpage>632</fpage>&#x02010;<lpage>644</lpage>.<pub-id pub-id-type="pmid">24194504</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0040">
<string-name>
<surname>Wolf</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Daft</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Tanner</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Hartmann</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Khafipour</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Lorenz</surname>
<given-names>RG</given-names>
</string-name>. <article-title>Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice</article-title>. <source xml:lang="en">J Histochem Cytochem</source>. <year>2014</year>;<volume>62</volume>(<issue>4</issue>):<fpage>237</fpage>&#x02010;<lpage>250</lpage>.<pub-id pub-id-type="pmid">24453191</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0041">
<string-name>
<surname>Alkanani</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Hara</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Gottlieb</surname>
<given-names>PA</given-names>
</string-name>, et al. <article-title>Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes</article-title>. <source xml:lang="en">Diabetes</source>. <year>2015</year>;<volume>64</volume>:<fpage>3510</fpage>&#x02010;<lpage>3520</lpage>.<pub-id pub-id-type="pmid">26068542</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0042">
<string-name>
<surname>Wen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ley</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Volchkov</surname>
<given-names>PY</given-names>
</string-name>, et al. <article-title>Innate immunity and intestinal microbiota in the development of type 1 diabetes</article-title>. <source xml:lang="en">Nature</source>. <year>2008</year>;<volume>455</volume>(<issue>7216</issue>):<fpage>1109</fpage>&#x02010;<lpage>1113</lpage>.<pub-id pub-id-type="pmid">18806780</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0043">
<string-name>
<surname>King</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sarvetnick</surname>
<given-names>N</given-names>
</string-name>. <article-title>The incidence of type&#x02010;1 diabetes in NOD mice is modulated by restricted flora not germ&#x02010;free conditions</article-title>. <source xml:lang="en">PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>2</issue>):<elocation-id>e17049</elocation-id>.<pub-id pub-id-type="pmid">21364875</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0044">
<string-name>
<surname>Tai</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice</article-title>. <source xml:lang="en">J Exp Med</source>. <year>2016</year>;<volume>213</volume>(<issue>10</issue>):<fpage>2129</fpage>&#x02010;<lpage>2146</lpage>.<pub-id pub-id-type="pmid">27621416</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0045">
<string-name>
<surname>Knip</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Honkanen</surname>
<given-names>J</given-names>
</string-name>. <article-title>Modulation of type 1 diabetes risk by the intestinal microbiome</article-title>. <source xml:lang="en">Curr Diab Rep</source>. <year>2017</year>;<volume>17</volume>(<issue>11</issue>):<fpage>105</fpage>.<pub-id pub-id-type="pmid">28942491</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0046">
<string-name>
<surname>Giongo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gano</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Crabb</surname>
<given-names>DB</given-names>
</string-name>, et al. <article-title>Toward defining the autoimmune microbiome for type 1 diabetes</article-title>. <source xml:lang="en">ISME J</source>. <year>2011</year>;<volume>5</volume>(<issue>1</issue>):<fpage>82</fpage>&#x02010;<lpage>91</lpage>.<pub-id pub-id-type="pmid">20613793</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0047">
<string-name>
<surname>Davis&#x02010;Richardson</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Ardissone</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Dias</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>
<italic>Bacteroides dorei</italic> dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes</article-title>. <source xml:lang="en">Front Microbiol</source>. <year>2014</year>;<volume>5</volume>:<fpage>678</fpage>.<pub-id pub-id-type="pmid">25540641</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0048">
<string-name>
<surname>de Goffau</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Fuentes</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>van den Bogert</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Aberrant gut microbiota composition at the onset of type 1 diabetes in young children</article-title>. <source xml:lang="en">Diabetologia</source>. <year>2014</year>;<volume>57</volume>(<issue>8</issue>):<fpage>1569</fpage>&#x02010;<lpage>1577</lpage>.<pub-id pub-id-type="pmid">24930037</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0049">
<string-name>
<surname>de Goffau</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Luopajarvi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Knip</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Fecal microbiota composition differs between children with beta&#x02010;cell autoimmunity and those without</article-title>. <source xml:lang="en">Diabetes</source>. <year>2013</year>;<volume>62</volume>(<issue>4</issue>):<fpage>1238</fpage>&#x02010;<lpage>1244</lpage>.<pub-id pub-id-type="pmid">23274889</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0050">
<string-name>
<surname>Vaarala</surname>
<given-names>O</given-names>
</string-name>. <article-title>Human intestinal microbiota and type 1 diabetes</article-title>. <source xml:lang="en">Curr Diab Rep</source>. <year>2013</year>;<volume>13</volume>(<issue>5</issue>):<fpage>601</fpage>&#x02010;<lpage>607</lpage>.<pub-id pub-id-type="pmid">23934614</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0051">
<string-name>
<surname>Brown</surname>
<given-names>CT</given-names>
</string-name>, <string-name>
<surname>Davis&#x02010;Richardson</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Giongo</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes</article-title>. <source xml:lang="en">PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>10</issue>):<elocation-id>e25792</elocation-id>.<pub-id pub-id-type="pmid">22043294</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0052">
<string-name>
<surname>Krych</surname>
<given-names>&#x00141;</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>CHF</given-names>
</string-name>. <article-title>Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN&#x02010;&#x003b3;level in NOD mice</article-title>. <source xml:lang="en">Gut Microbes</source>. <year>2015</year>;<volume>6</volume>(<issue>2</issue>):<fpage>101</fpage>&#x02010;<lpage>109</lpage>.<pub-id pub-id-type="pmid">25648687</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0053">
<string-name>
<surname>Hara</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Alkanani</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Ir</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>The role of the intestinal microbiota in type 1 diabetes</article-title>. <source xml:lang="en">Clin Immunol</source>. <year>2013</year>;<volume>146</volume>(<issue>2</issue>):<fpage>112</fpage>&#x02010;<lpage>119</lpage>.<pub-id pub-id-type="pmid">23314185</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0054">
<string-name>
<surname>Mej&#x000ed;a&#x02010;Le&#x000f3;n</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Barca</surname>
<given-names>A</given-names>
</string-name>. <article-title>Diet, microbiota and immune system in type 1 diabetes development and evolution</article-title>. <source xml:lang="en">Nutrients</source>. <year>2015</year>;<volume>7</volume>(<issue>11</issue>):<fpage>9171</fpage>&#x02010;<lpage>9184</lpage>.<pub-id pub-id-type="pmid">26561831</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0055">
<string-name>
<surname>Kostic</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Gevers</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Siljander</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes</article-title>. <source xml:lang="en">Cell Host Microbe</source>. <year>2015</year>;<volume>17</volume>(<issue>2</issue>):<fpage>260</fpage>&#x02010;<lpage>273</lpage>.<pub-id pub-id-type="pmid">25662751</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0056">
<string-name>
<surname>Patterson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Marques</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>O'Sullivan</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Streptozotocin&#x02010;induced type&#x02010;1&#x02010;diabetes disease onset in Sprague&#x02010;Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity</article-title>. <source xml:lang="en">Microbiology</source>. <year>2015</year>;<volume>161</volume>(<issue>1</issue>):<fpage>182</fpage>&#x02010;<lpage>193</lpage>.<pub-id pub-id-type="pmid">25370749</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0057">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Atkinson</surname>
<given-names>MA</given-names>
</string-name>. <article-title>The role for gut permeability in the pathogenesis of type 1 diabetes&#x02014;a solid or leaky concept?</article-title>
<source xml:lang="en">Pediatr Diabetes</source>. <year>2015</year>;<volume>16</volume>(<issue>7</issue>):<fpage>485</fpage>&#x02010;<lpage>492</lpage>.<pub-id pub-id-type="pmid">26269193</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0058">
<string-name>
<surname>Maffeis</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Martina</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Corradi</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes</article-title>. <source xml:lang="en">Diabetes Metab Res Rev</source>. <year>2016</year>;<volume>32</volume>(<issue>7</issue>):<fpage>700</fpage>&#x02010;<lpage>709</lpage>.<pub-id pub-id-type="pmid">26891226</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0059">
<string-name>
<surname>Ohkusa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Okayasu</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ogihara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Morita</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ogawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>N</given-names>
</string-name>. <article-title>Induction of experimental ulcerative colitis by <italic>Fusobacterium varium</italic> isolated from colonic mucosa of patients with ulcerative colitis</article-title>. <source xml:lang="en">Gut</source>. <year>2003</year>;<volume>52</volume>(<issue>1</issue>):<fpage>79</fpage>&#x02010;<lpage>83</lpage>.<pub-id pub-id-type="pmid">12477765</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0060">
<string-name>
<surname>Strauss</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kaplan</surname>
<given-names>GG</given-names>
</string-name>, <string-name>
<surname>Beck</surname>
<given-names>PL</given-names>
</string-name>, et al. <article-title>Invasive potential of gut mucosa&#x02010;derived <italic>Fusobacterium nucleatum</italic> positively correlates with IBD status of the host</article-title>. <source xml:lang="en">Inflamm Bowel Dis</source>. <year>2011</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1971</fpage>&#x02010;<lpage>1978</lpage>.<pub-id pub-id-type="pmid">21830275</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0061">
<string-name>
<surname>Legaria</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Lumelsky</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rodriguez</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rosetti</surname>
<given-names>S</given-names>
</string-name>. <article-title>Clindamycin&#x02010;resistant <italic>Fusobacterium varium</italic> bacteremia and decubitus ulcer infection</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2005</year>;<volume>43</volume>(<issue>8</issue>):<fpage>4293</fpage>&#x02010;<lpage>4295</lpage>.<pub-id pub-id-type="pmid">16082005</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0062">
<string-name>
<surname>Hevia</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Milani</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lopez</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Intestinal dysbiosis associated with systemic lupus erythematosus</article-title>. <source xml:lang="en">MBio</source>. <year>2014</year>;<volume>5</volume>:<fpage>e1514</fpage>&#x02010;<lpage>e1548</lpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0063">
<string-name>
<surname>Schickel</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Glauzy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>YS</given-names>
</string-name>, et al. <article-title>Self&#x02010;reactive VH4&#x02010;34&#x02010;expressing IgG B cells recognize commensal bacteria</article-title>. <source xml:lang="en">J Exp Med</source>. <year>2017</year>;<volume>214</volume>(<issue>7</issue>):<fpage>2161</fpage>.<pub-id pub-id-type="pmid">28522685</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0064">
<string-name>
<surname>Hebbandi</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Ronchi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>A gut microbial mimic that hijacks Diabetogenic autoreactivity to suppress colitis</article-title>. <source xml:lang="en">Cell</source>. <year>2017</year>;<volume>171</volume>(<issue>3</issue>):<fpage>655</fpage>&#x02010;<lpage>667</lpage>.<pub-id pub-id-type="pmid">29053971</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0065">
<string-name>
<surname>Ferris</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Zakharov</surname>
<given-names>PN</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>The islet&#x02010;resident macrophage is in an inflammatory state and senses microbial products in blood</article-title>. <source xml:lang="en">J Exp Med</source>. <year>2017</year>;<volume>214</volume>(<issue>8</issue>):<fpage>2369</fpage>&#x02010;<lpage>2385</lpage>.<pub-id pub-id-type="pmid">28630088</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0066">
<string-name>
<surname>Willcox</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Richardson</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Bone</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Foulis</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Morgan</surname>
<given-names>NG</given-names>
</string-name>. <article-title>Analysis of islet inflammation in human type 1 diabetes</article-title>. <source xml:lang="en">Clin Exp Immunol</source>. <year>2009</year>;<volume>155</volume>(<issue>2</issue>):<fpage>173</fpage>&#x02010;<lpage>181</lpage>.<pub-id pub-id-type="pmid">19128359</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0067">
<string-name>
<surname>Janeway</surname>
<given-names>CJ</given-names>
</string-name>. <article-title>Approaching the asymptote? Evolution and revolution in immunology</article-title>. <source xml:lang="en">Cold Spring Harb Symp Quant Biol</source>. <year>1989</year>;<volume>54</volume>(<issue>0</issue>):<fpage>1</fpage>&#x02010;<lpage>13</lpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0068">
<string-name>
<surname>Akira</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Uematsu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takeuchi</surname>
<given-names>O</given-names>
</string-name>. <article-title>Pathogen recognition and innate immunity</article-title>. <source xml:lang="en">Cell</source>. <year>2006</year>;<volume>124</volume>(<issue>4</issue>):<fpage>783</fpage>&#x02010;<lpage>801</lpage>.<pub-id pub-id-type="pmid">16497588</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0069">
<string-name>
<surname>Kieser</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Kagan</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Multi&#x02010;receptor detection of individual bacterial products by the innate immune system</article-title>. <source xml:lang="en">Nat Rev Immunol</source>. <year>2017</year>;<volume>77</volume>:<fpage>376</fpage>&#x02010;<lpage>390</lpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0070">
<string-name>
<surname>Burrows</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Volchkov</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Chervonsky</surname>
<given-names>AV</given-names>
</string-name>. <article-title>Microbiota regulates type 1 diabetes through toll&#x02010;like receptors</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>2015</year>;<volume>112</volume>(<issue>32</issue>):<fpage>9973</fpage>&#x02010;<lpage>9977</lpage>.<pub-id pub-id-type="pmid">26216961</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0071">
<string-name>
<surname>McCoy</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Ronchi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Geuking</surname>
<given-names>MB</given-names>
</string-name>. <article-title>Host&#x02010;microbiota interactions and adaptive immunity</article-title>. <source xml:lang="en">Immunol Rev</source>. <year>2017</year>;<volume>279</volume>(<issue>1</issue>):<fpage>63</fpage>&#x02010;<lpage>69</lpage>.<pub-id pub-id-type="pmid">28856735</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0072">
<string-name>
<surname>Ivanov</surname>
<given-names>II</given-names>
</string-name>, <string-name>
<surname>Atarashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Manel</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Induction of intestinal Th17 cells by segmented filamentous bacteria</article-title>. <source xml:lang="en">Cell</source>. <year>2009</year>;<volume>139</volume>(<issue>3</issue>):<fpage>485</fpage>&#x02010;<lpage>498</lpage>.<pub-id pub-id-type="pmid">19836068</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0073">
<string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gagliani</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ishigame</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>2017</year>;<volume>114</volume>(<issue>39</issue>):<fpage>10443</fpage>&#x02010;<lpage>10448</lpage>.<pub-id pub-id-type="pmid">28894001</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0074">
<string-name>
<surname>Cummings</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Pomare</surname>
<given-names>EW</given-names>
</string-name>, <string-name>
<surname>Branch</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Naylor</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</string-name>. <article-title>Short chain fatty acids in human large intestine, portal, hepatic and venous blood</article-title>. <source xml:lang="en">Gut</source>. <year>1987</year>;<volume>28</volume>(<issue>10</issue>):<fpage>1221</fpage>&#x02010;<lpage>1227</lpage>.<pub-id pub-id-type="pmid">3678950</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0075">
<string-name>
<surname>Postler</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</string-name>. <article-title>Understanding the holobiont: how microbial metabolites affect human health and shape the immune system</article-title>. <source xml:lang="en">Cell Metab</source>. <year>2017</year>;<volume>26</volume>(<issue>1</issue>):<fpage>110</fpage>&#x02010;<lpage>130</lpage>.<pub-id pub-id-type="pmid">28625867</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0076">
<string-name>
<surname>Arpaia</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Metabolites produced by commensal bacteria promote peripheral regulatory T&#x02010;cell generation</article-title>. <source xml:lang="en">Nature</source>. <year>2013</year>;<volume>504</volume>(<issue>7480</issue>):<fpage>451</fpage>&#x02010;<lpage>455</lpage>.<pub-id pub-id-type="pmid">24226773</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0077">
<string-name>
<surname>Mari&#x000f1;o</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Richards</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>McLeod</surname>
<given-names>KH</given-names>
</string-name>, et al. <article-title>Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes</article-title>. <source xml:lang="en">Nat Immunol</source>. <year>2017</year>;<volume>18</volume>(<issue>5</issue>):<fpage>552</fpage>&#x02010;<lpage>562</lpage>.<pub-id pub-id-type="pmid">28346408</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0078">
<string-name>
<surname>Round</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</string-name>. <article-title>Inducible Foxp3+ regulatory T&#x02010;cell development by a commensal bacterium of the intestinal microbiota</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>27</issue>):<fpage>12204</fpage>&#x02010;<lpage>12209</lpage>.<pub-id pub-id-type="pmid">20566854</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0079">
<string-name>
<surname>Furusawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Obata</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fukuda</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Commensal microbe&#x02010;derived butyrate induces the differentiation of colonic regulatory T cells</article-title>. <source xml:lang="en">Nature</source>. <year>2013</year>;<volume>504</volume>(<issue>7480</issue>):<fpage>446</fpage>&#x02010;<lpage>450</lpage>.<pub-id pub-id-type="pmid">24226770</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0080">
<string-name>
<surname>Kudoh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wada</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Effect of indigestible saccharides on B lymphocyte response of intestinal mucosa and cecal fermentation in rats</article-title>. <source xml:lang="en">J Nutr Sci Vitaminol (Tokyo)</source>. <year>1998</year>;<volume>44</volume>(<issue>1</issue>):<fpage>103</fpage>&#x02010;<lpage>112</lpage>.<pub-id pub-id-type="pmid">9591238</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0081">
<string-name>
<surname>Kim</surname>
<given-names>CH</given-names>
</string-name>. <article-title>B cell&#x02010;helping functions of gut microbial metabolites</article-title>. <source xml:lang="en">Microb Cell</source>. <year>2016</year>;<volume>3</volume>(<issue>10</issue>):<fpage>529</fpage>&#x02010;<lpage>531</lpage>.<pub-id pub-id-type="pmid">28357321</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0082">
<string-name>
<surname>Kim</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Qie</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>CH</given-names>
</string-name>. <article-title>Gut microbial metabolites fuel host antibody responses</article-title>. <source xml:lang="en">Cell Host Microbe</source>. <year>2016</year>;<volume>20</volume>(<issue>2</issue>):<fpage>202</fpage>&#x02010;<lpage>214</lpage>.<pub-id pub-id-type="pmid">27476413</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0083">
<string-name>
<surname>Calcinaro</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Dionisi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Marinaro</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Oral probiotic administration induces interleukin&#x02010;10 production and prevents spontaneous autoimmune diabetes in the non&#x02010;obese diabetic mouse</article-title>. <source xml:lang="en">Diabetologia</source>. <year>2005</year>;<volume>48</volume>(<issue>8</issue>):<fpage>1565</fpage>&#x02010;<lpage>1575</lpage>.<pub-id pub-id-type="pmid">15986236</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0084">
<string-name>
<surname>Zhu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Winter</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Byndloss</surname>
<given-names>MX</given-names>
</string-name>, et al. <article-title>Precision editing of the gut microbiota ameliorates colitis</article-title>. <source xml:lang="en">Nature</source>. <year>2018</year>;<volume>553</volume>(<issue>7687</issue>):<fpage>208</fpage>&#x02010;<lpage>211</lpage>.<pub-id pub-id-type="pmid">29323293</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0085">
<string-name>
<surname>Lee</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ko</surname>
<given-names>G</given-names>
</string-name>. <article-title>Effect of metformin on metabolic improvement and gut microbiota</article-title>. <source xml:lang="en">Appl Environ Microbiol</source>. <year>2014</year>;<volume>80</volume>(<issue>19</issue>):<fpage>5935</fpage>&#x02010;<lpage>5943</lpage>.<pub-id pub-id-type="pmid">25038099</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0086">
<string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>B</given-names>
</string-name>. <article-title>Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2016</year>;<volume>6</volume>(<issue>1</issue>):<elocation-id>33251</elocation-id>.<pub-id pub-id-type="pmid">27633081</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0087">
<string-name>
<surname>Kihl</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Krych</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Buschard</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Oral insulin does not alter gut microbiota composition of NOD mice</article-title>. <source xml:lang="en">Diabetes Metab Res Rev</source>. <year>2018</year>;<volume>34</volume>(<issue>6</issue>):<elocation-id>e3010</elocation-id>.<pub-id pub-id-type="pmid">29637693</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0088">
<string-name>
<surname>Raz</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Elias</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Avron</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tamir</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Metzger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>IR</given-names>
</string-name>. <article-title>&#x003b2;&#x02010;Cell function in new&#x02010;onset type 1 diabetes and immunomodulation with a heat&#x02010;shock protein peptide (DiaPep277): a randomised, double&#x02010;blind, phase II trial</article-title>. <source xml:lang="en">Lancet</source>. <year>2001</year>;<volume>358</volume>(<issue>9295</issue>):<fpage>1749</fpage>&#x02010;<lpage>1753</lpage>.<pub-id pub-id-type="pmid">11734230</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0089">
<string-name>
<surname>Fenalti</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rowley</surname>
<given-names>M</given-names>
</string-name>. <article-title>GAD65 as a prototypic autoantigen</article-title>. <source xml:lang="en">J Autoimmun</source>. <year>2008</year>;<volume>32</volume>:<fpage>228</fpage>&#x02010;<lpage>232</lpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0090">
<string-name>
<surname>Chatenoud</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Thervet</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Primo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bach</surname>
<given-names>JF</given-names>
</string-name>. <article-title>Anti&#x02010;CD3 antibody induces long&#x02010;term remission of overt autoimmunity in nonobese diabetic mice</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>1994</year>;<volume>91</volume>(<issue>1</issue>):<fpage>123</fpage>&#x02010;<lpage>127</lpage>.<pub-id pub-id-type="pmid">8278351</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0091">
<string-name>
<surname>Alegre</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>A non&#x02010;activating &#x0201c;humanized&#x0201d; anti&#x02010;CD3 monoclonal antibody retains immunosuppressive properties in vivo</article-title>. <source xml:lang="en">Transplantation</source>. <year>1994</year>;<volume>57</volume>(<issue>11</issue>):<fpage>1537</fpage>&#x02010;<lpage>1543</lpage>.<pub-id pub-id-type="pmid">8009586</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0092">
<string-name>
<surname>Kremer</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Genant</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>Moreland</surname>
<given-names>LW</given-names>
</string-name>, et al. <article-title>Effects of abatacept in patients with methotrexate&#x02010;resistant active rheumatoid arthritis: a randomized trial</article-title>. <source xml:lang="en">Ann Intern Med</source>. <year>2006</year>;<volume>144</volume>(<issue>12</issue>):<fpage>865</fpage>&#x02010;<lpage>876</lpage>.<pub-id pub-id-type="pmid">16785475</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0093">
<string-name>
<surname>Hu</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Rodriguezpinto</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Treatment with CD20&#x02010;specific antibody prevents and reverses autoimmune diabetes in mice</article-title>. <source xml:lang="en">J Clin Invest</source>. <year>2007</year>;<volume>117</volume>(<issue>12</issue>):<fpage>3857</fpage>&#x02010;<lpage>3867</lpage>.<pub-id pub-id-type="pmid">18060033</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0094">
<string-name>
<surname>Waldron&#x02010;Lynch</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Henegariu</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Teplizumab induces human gut&#x02010;tropic regulatory cells in humanized mice and patients</article-title>. <source xml:lang="en">Sci Transl Med</source>. <year>2012</year>;<volume>4</volume>:<fpage>112r</fpage>&#x02010;<lpage>118r</lpage>.</mixed-citation></ref><ref id="dmrr3043-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0095">
<string-name>
<surname>Chang</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>CC</given-names>
</string-name>, et al. <article-title>Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota</article-title>. <source xml:lang="en">Nat Commun</source>. <year>2015</year>;<volume>6</volume>(<issue>1</issue>):<fpage>7489</fpage>.<pub-id pub-id-type="pmid">26102296</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0096">
<string-name>
<surname>Zheng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Suppression of pancreatic beta cell apoptosis by Danzhi Jiangtang capsule contributes to the attenuation of type 1 diabetes in rats</article-title>. <source xml:lang="en">BMC Complement Altern Med</source>. <year>2016</year>;<volume>16</volume>:<fpage>31</fpage>.<pub-id pub-id-type="pmid">26819084</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0097">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Casteels</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Frogne</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Artemisinins target GABA A receptor signaling and impair &#x003b1; cell identity</article-title>. <source xml:lang="en">Cell</source>. <year>2017</year>;<volume>168</volume>(<issue>1&#x02010;2</issue>):<fpage>86</fpage>&#x02010;<lpage>100</lpage>.<pub-id pub-id-type="pmid">27916275</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0098">
<string-name>
<surname>Michael</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lindsay</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Alessandro</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>2017</year>;<volume>114</volume>:<fpage>9671</fpage>&#x02010;<lpage>9676</lpage>.<pub-id pub-id-type="pmid">28831005</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0099">
<string-name>
<surname>Onengut&#x02010;Gumuscu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Burren</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers</article-title>. <source xml:lang="en">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>4</issue>):<fpage>381</fpage>&#x02010;<lpage>386</lpage>.<pub-id pub-id-type="pmid">25751624</pub-id></mixed-citation></ref><ref id="dmrr3043-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="dmrr3043-cit-0100">
<string-name>
<surname>Li</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Morrison</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Kovar</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Analysis of loss&#x02010;of&#x02010;function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease</article-title>. <source xml:lang="en">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>6</issue>):<fpage>640</fpage>&#x02010;<lpage>642</lpage>.<pub-id pub-id-type="pmid">25915599</pub-id></mixed-citation></ref></ref-list></back></article>